ACH news

Accendra Health extended the termination date of its $150 million receivables sale program to October 2029, maintaining the facility size.

The company received a notice of non-compliance regarding market cap and stockholders' equity but intends to submit a business plan to maintain its listing.

Accendra Health received a notice from NYSE that its stock has fallen below $1 per share for 30 consecutive days. The company plans to cure the issue in the next six months, potentially including a reverse stock split.

Accendra Health reported a second quarter net los of $89.1 million and completed a $385 million debt reduction. CEO Ed Pesicka announced his intention to retire by the end of 2026.

Accendra Health President and CEO Edward Pesicka will retire by the end of the year. The company has a robust succession plan in place, and a replacement will be selected through a comprehensive evaluation process.

Accendra Health announced exchange offers to swap outstanding 4.500% 2029 Notes and 6.625% 2030 Notes for newly issued 9.000% First Lien Notes due 2032 and 9.750% Second Lien Notes due 2033, along with consent solicitations to amend existing note indentures. The company is also raising $326.25 milli…